학술논문

Seroprevalence and related risk factors of Brucella spp. in livestock and humans in Garbatula subcounty, Isiolo county, Kenya.
Document Type
Article
Source
PLoS Neglected Tropical Diseases. 10/16/2023, Vol. 17 Issue 10, p1-19. 19p.
Subject
*BRUCELLA
*SCHMALLENBERG virus
*DISEASE risk factors
*SEROPREVALENCE
*ZOONOSES
*ENZYME-linked immunosorbent assay
*ANIMAL herds
Language
ISSN
1935-2727
Abstract
Background: Brucellosis is a neglected zoonotic disease that affects both animals and humans, causing debilitating illness in humans and socio-economic losses in livestock-keeping households globally. The disease is endemic in many developing countries, including Kenya, but measures to prevent and control the disease are often inadequate among high-risk populations. This study aimed to investigate the human and livestock seroprevalence of brucellosis and associated risk factors of Brucella spp. in a pastoralist region of northern Kenya. Methods: A cross-sectional survey was conducted using a two-stage cluster sampling method to select households, livestock, and humans for sampling. Blood samples were collected from 683 humans and 2157 animals, and Brucella immunoglobulin G (IgG) antibodies were detected using enzyme-linked immunosorbent assays. A structured questionnaire was used to collect data on potential risk factors associated with human and animal exposures. Risk factors associated with Brucella spp. exposures in humans and livestock were identified using Multivariate logistic regression. Results: The results indicated an overall livestock Brucella spp. seroprevalence of 10.4% (95% Confidence Interval (CI): 9.2–11.7). Camels had the highest exposure rates at 19.6% (95% CI: 12.4–27.3), followed by cattle at 13.2% (95% CI: 9.3–17.1), goats at 13.1% (95% CI: 11.1–15.3) and sheep at 5.4% (95% CI: 4.0–6.9). The herd-level seroprevalence was 51.7% (95% CI, 47.9–55.7). Adult animals (Adjusted Odds Ratio (aOR) = 2.3, CI = 1.3–4.0), female animals (aOR = 1.7, CI: 1.1–2.6), and large herd sizes (aOR = 2.3, CI = 1.3–4.0) were significantly associated with anti-brucella antibody detection while sheep had significantly lower odds of Brucella spp. exposure compared to cattle (aOR = 1.3, CI = 0.8–2.1) and camels (aOR = 2.4, CI = 1.2–4.8). Human individual and household seroprevalences were 54.0% (95 CI, 50.2–58.0) and 86.4% (84.0–89.0), respectively. Significant risk factors associated with human seropositivity included being male (aOR = 2.1, CI:1.3–3.2), residing in Sericho ward (aOR = 1.6, CI:1.1–2.5) and having no formal education (aOR = 3.0, CI:1.5–5.9). There was a strong correlation between human seropositivity and herd exposure (aOR = 1.6, CI:1.2–2.3). Conclusions: The study provides evidence of high human and livestock exposures to Brucella spp. and identifies important risk factors associated with disease spread. These findings emphasize the need for targeted prevention and control measures to curb the spread of brucellosis and implement a One Health surveillance to ensure early detection of the disease in Isiolo County, Northern Kenya. Author summary: Brucellosis is a priority zoonotic disease in Kenya that causes human illness and socio-economic losses in livestock-keeping households. We conducted a linked human-livestock study to investigate the seroprevalence of Brucella spp.. We also identified risk factors associated with brucellosis seropositivity. The study found a high seroprevalence in humans and animals and identified significant risk factors associated with livestock exposure, which included adult animals, female animals, and large herd sizes. In humans, significant risk factors included being male, residing in a specific ward, and having no formal education. We also found a strong correlation between human seropositivity and herd exposure. Implementing interventions such as promoting public awareness about the disease, safe handling of livestock and livestock products, and livestock vaccinations can potentially reduce the disease transmission in livestock and spill over to humans. Future studies should examine the efficacy of measures that reduce these risk factors to mitigate the spread of brucellosis. [ABSTRACT FROM AUTHOR]